Novo Integrated Sciences, Inc.

OTCPK:NVOS Stock Report

Market Cap: US$1.0m

Novo Integrated Sciences Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Novo Integrated Sciences.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth20.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Slammed 49% Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Screens Well Here But There Might Be A Catch

Jul 11
Slammed 49% Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Screens Well Here But There Might Be A Catch

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Looks Just Right With A 26% Price Jump

Apr 18
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Looks Just Right With A 26% Price Jump

Novo Integrated Sciences prices 4M unit public offering at $.50/unit

Oct 14

Novo Integrated Sciences expects to report over fivefold increase in Q3 revenue

Jul 11

Health Check: How Prudently Does Novo Integrated Sciences (NASDAQ:NVOS) Use Debt?

Nov 23
Health Check: How Prudently Does Novo Integrated Sciences (NASDAQ:NVOS) Use Debt?

Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?

Aug 07
Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?

Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?

Mar 02
Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Novo Integrated Sciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OTCPK:NVOS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
5/31/202414-24-5-5N/A
2/29/202414-12-5-5N/A
11/30/202313-14-4-4N/A
8/31/202313-13-2-2N/A
5/31/20231-32-1-1N/A
2/28/202312-35-4-4N/A
11/30/202212-35-5-5N/A
8/31/202212-33-6-6N/A
5/31/202223-12-8-7N/A
2/28/202211-9-4-4N/A
11/30/202110-5-2-2N/A
8/31/20219-4-1-1N/A
5/31/20218-7-10N/A
2/28/20217-600N/A
11/30/20207-600N/A
8/31/20208-500N/A
5/31/20208-1-1-1N/A
2/29/202010-1-1-1N/A
11/30/2019100-1-1N/A
8/31/201990-1-1N/A
5/31/20199-1-1-1N/A
2/28/20199-1-1-1N/A
11/30/20189-2-1-1N/A
8/31/20189-2-1-1N/A
5/31/20189-2-1-1N/A
2/28/20189-2N/A-1N/A
11/30/20178-1N/A-1N/A
8/31/20178-1N/A-1N/A
5/31/20178-1N/A-1N/A
2/28/201770N/A-1N/A
11/30/201670N/A0N/A
8/31/201670N/A0N/A
8/31/20157-2N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if NVOS's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if NVOS's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if NVOS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if NVOS's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if NVOS's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NVOS's Return on Equity is forecast to be high in 3 years time


Discover growth companies